Infectious Diseases/Pandemics Policy Lab
"Our common enemy is right here, right among us, and within us. That common enemy is disease, disease that affects all of humankind indiscriminately, without regard for race, sex, or geographic location"
- Andrew von Eschenbach, U.S. Food and Drug Administration
(2007 Summit)
Lab Architecture
The Infectious Diseases/Pandemics Policy Lab is managed by the NBR Center for Health and Aging—the Secretariat for the Pacific Health Summit. The lab is organized into two modules designed to tackle the distinct challenges posed by emerging infectious diseases such as avian flu and MDR-TB as well as the continuing threats of TB, cholera, and other diseases while acknowledging the common infrastructure that can be employed toward creating an effective health systems response.

back to top
Origin and Focus
Spirited panel discussions at the 2005 Pacific Health Summit launched the creation of the Infectious Diseases/Pandemics Policy Lab. The goal of this Lab is to contribute research and support to saving lives and minimizing the economic impact of infectious diseases and continuing pandemics. Toward this end, the lab aims to leverage common infrastructure and best practices through targeted workshops, case studies, and briefings. Areas for research and discussion include:
- Facilitating communication about scientific and policy developments surrounding infectious diseases and pandemics among key stakeholders in science, medicine, policy, public health, and industry.
- Providing educational resources for key stakeholders in the field of infectious diseases/pandemics.
back to top
Targeted, Outcome-Oriented Meetings
Seattle, 2007. The focus of the Pacific Health Summit in 2007 was “Pandemics: Working Together for an Effective and Equitable Response.” This three day conference was co-presented by the NBR Center for Health and Aging, the Bill & Melinda Gates Foundation, and the Fred Hutchinson Cancer Research Center. Participants discussed the challenges presented by avian flu and other emerging communicable and non-communicable pandemics. At the top of the agenda were issues such as the building of vaccine manufacturing capacity and the establishment of financial mechanisms and tiered pricing structures to increase developing countries’ access to pandemic and pre-pandemic influenza vaccines.
Beijing, 2007. The NBR Center for Health and Aging and Chinese CDC co-presented a workshop on pandemic influenza vaccines in January 2007 in Beijing. The workshop goal was to improve the global environment for avian influenza vaccine research, development manufacturing, regulation, and dissemination, and by doing so create a platform for global collaboration on vaccines. A report of key findings from the workshop can be found here.
back to top
Publications and Online Resources
- Online Resources. A comprehensive resource for those interested in the history and evolving developments in pandemic influenza vaccines and tuberculosis, which provides background research, international policy resources, and key organizations. Additionally, a calendar of key meetings related to pandemic influenza vaccines.
back to top